Industry Standard Ligand Binding Assays
Enzyme-linked immunosorbent assays (ELISA) are the most common method for ligand binding assays and are a core competency at Scorpius. ELISA is a fast, reliable, and cost-effective platform for analyte quantification of specific assays used for testing of biologics, as well as cell and gene therapies.
Scorpius has extensive experience developing, optimizing, and validating ELISA test methods. Our team is proficient in single analyte and multiplexed analyses, with traditional colorimetric readouts, as well as electrochemiluminescence readouts. We develop ELISA methods spanning the range of biological matrices from serum and plasma, urine, whole cells, cell, and tissue lysates and various biotherapeutics.
- Commercial kit-based
- Functional assays
- ADA (sandwich ELISA, bridging assay with protein labeling)